Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NPIPB10P is classified as a pseudogene, meaning it shares sequence similarity with other members of the nuclear pore complex interacting protein family but does not encode a functional protein. This locus is located on human chromosome 16 and is registered under HGNC ID HGNC:37455 and NCBI Gene ID: 730153. There is no documented function, disease association, or drug interaction, and it is not considered a therapeutic target. Its primary relevance is as a genomic marker, and not as a biologically active molecule. NPIPB10P thus represents a pseudogene, not a protein-coding gene or actionable drug target. This makes it generally irrelevant for drug development, functional studies, or disease targeting, unless future research clarifies novel non-coding RNA or regulatory functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore complex interacting protein family, member B10, pseudogene (NPIPB10P).